Skip to main content
logo
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
13.76
+0.10 (0.73%)
Aug 26, 2026, 1:23 PM EDT - Market open

TNXP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
236194622422177
Market Cap Growth
-29.11%214.02%160.94%5.35%-87.36%37.35%
Enterprise Value
6144218-117-4
Last Close Price
13.6615.6232.981289.607796.00228928.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.0414.776.113.04--
PB Ratio
1.030.790.440.220.110.81
P/TBV Ratio
1.050.790.440.250.110.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.030.304.172.30--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.060.090.000.00
Net Debt / Equity Ratio
-0.79-0.84-0.65-0.14-0.58-0.81
Net Debt / EBITDA Ratio
1.071.671.220.131.081.93
Net Debt / FCF Ratio
1.112.001.490.140.821.60
Asset Turnover
0.130.060.060.04--
Inventory Turnover
0.810.860.69---
Quick Ratio
6.126.965.851.336.618.23
Current Ratio
6.617.426.502.537.198.71
Return on Equity (ROE)
-81.82%-64.48%-106.12%-74.61%-51.76%-60.25%
Return on Assets (ROA)
-46.84%-35.71%-30.62%-38.93%-30.03%-34.03%
Return on Capital Employed (ROCE)
-74.10%-51.00%-53.80%-87.30%-54.00%-42.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-68.20%-64.08%-210.97%-493.86%-491.58%-52.02%
FCF Yield
-67.54%-53.33%-99.04%-465.24%-652.06%-62.49%
Buyback Yield / Dilution
-216.89%-1055.90%----
SEC Filings: 10-K · 10-Q